These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 30918666)

  • 1. The Atrial Phenotype of the Inherited Primary Arrhythmia Syndromes.
    Conte G; Schotten U; Auricchio A
    Arrhythm Electrophysiol Rev; 2019 Mar; 8(1):42-46. PubMed ID: 30918666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autonomic cardiac innervation: impact on the evolution of arrhythmias in inherited cardiac arrhythmia syndromes.
    Maury P; Delasnerie H; Beneyto M; Rollin A
    Herzschrittmacherther Elektrophysiol; 2021 Sep; 32(3):308-314. PubMed ID: 34185133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation in inherited cardiac channelopathies: From mechanisms to management.
    Enriquez A; Antzelevitch C; Bismah V; Baranchuk A
    Heart Rhythm; 2016 Sep; 13(9):1878-84. PubMed ID: 27291509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced fatal arrhythmias: Acquired long QT and Brugada syndromes.
    Turker I; Ai T; Itoh H; Horie M
    Pharmacol Ther; 2017 Aug; 176():48-59. PubMed ID: 28527921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome.
    Kaufman ES
    Heart Rhythm; 2009 Aug; 6(8 Suppl):S51-5. PubMed ID: 19631908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy in inherited and acquired ventricular arrhythmia in structurally normal adult hearts.
    Ortmans S; Daval C; Aguilar M; Compagno P; Cadrin-Tourigny J; Dyrda K; Rivard L; Tadros R
    Expert Opin Pharmacother; 2019 Dec; 20(17):2101-2114. PubMed ID: 31566420
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary Electrical Heart Disease-Principles of Pathophysiology and Genetics.
    Badura K; Buławska D; Dąbek B; Witkowska A; Lisińska W; Radzioch E; Skwira S; Młynarska E; Rysz J; Franczyk B
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy for inherited arrhythmia syndromes: mechanistic basis, clinical trial evidence and practical application.
    Tadros R; Cadrin-Tourigny J; Abadir S; Rivard L; Nattel S; Talajic M; Khairy P
    Expert Rev Cardiovasc Ther; 2015; 13(7):769-82. PubMed ID: 25994014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sudden cardiac death in Long QT syndrome (LQTS), Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia (CPVT).
    Singh M; Morin DP; Link MS
    Prog Cardiovasc Dis; 2019; 62(3):227-234. PubMed ID: 31078562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proarrhythmogenic role of autonomics and emerging neuromodulation approaches to prevent sudden death in cardiac ion channelopathies.
    Tonko JB; Lambiase PD
    Cardiovasc Res; 2024 Mar; 120(2):114-131. PubMed ID: 38195920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification of spatial dispersion of repolarization underlies sudden cardiac death associated with catecholaminergic polymorphic VT, long QT, short QT and Brugada syndromes.
    Antzelevitch C; Oliva A
    J Intern Med; 2006 Jan; 259(1):48-58. PubMed ID: 16336513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherited Arrhythmia Syndromes.
    Kim JA; Chelu MG
    Tex Heart Inst J; 2021 Sep; 48(4):. PubMed ID: 34669951
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic basis of malignant channelopathies and ventricular fibrillation in the structurally normal heart.
    Hofman N; van Lochem LT; Wilde AA
    Future Cardiol; 2010 May; 6(3):395-408. PubMed ID: 20462344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ion Channel Disorders and Sudden Cardiac Death.
    Garcia-Elias A; Benito B
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arrhythmogenic hereditary syndromes: Brugada Syndrome, long QT syndrome, short QT syndrome and CPVT.
    Schimpf R; Veltmann C; Wolpert C; Borggrefe M
    Minerva Cardioangiol; 2010 Dec; 58(6):623-36. PubMed ID: 21135804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Features of Genetic Cardiac Diseases Related to Potassium Channelopathies.
    Adler A; Viskin S
    Card Electrophysiol Clin; 2016 Jun; 8(2):361-72. PubMed ID: 27261827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unveiling specific triggers and precipitating factors for fatal cardiac events in inherited arrhythmia syndromes.
    Nakajima T; Kaneko Y; Kurabayashi M
    Circ J; 2015; 79(6):1185-92. PubMed ID: 25925977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inherited primary arrhythmia disorders: cardiac channelopathies and sports activity.
    Marrakchi S; Kammoun I; Bennour E; Laroussi L; Ben Miled M; Kachboura S
    Herz; 2020 Apr; 45(2):142-157. PubMed ID: 29744527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient Outcomes From a Specialized Inherited Arrhythmia Clinic.
    Adler A; Sadek MM; Chan AY; Dell E; Rutberg J; Davis D; Green MS; Spears DA; Gollob MH
    Circ Arrhythm Electrophysiol; 2016 Jan; 9(1):e003440. PubMed ID: 26743238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial Fibrillation in Inherited Channelopathies.
    Al-Azaam B; Darbar D
    Card Electrophysiol Clin; 2021 Mar; 13(1):155-163. PubMed ID: 33516393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.